Business Context and Reporting Period
Envue Medical, Inc. (Nasdaq: FEED) filed a Form 8-K on August 14, 2026, reporting the final results of a Special Meeting of Stockholders held on the same date. The company is incorporated in Delaware and operates from Tyler, Texas.
Key Financial Metrics
This filing is a current report regarding corporate governance and stockholder voting results. It does not contain financial statements, revenue, profit, cash flow, margin, debt, or liquidity data.
Material Changes and Voting Results
Stockholders voted on two primary proposals:
- Proposal No. 1: Reverse Stock Split
- Status: Approved.
- Details: Authorizes the Board to effect a reverse stock split of outstanding common stock at a ratio between 1-for-2 and 1-for-50. The specific ratio and timing (within one year) are at the Board's discretion.
- Votes: 3,847,974 For; 1,062,981 Against; 19,288 Abstain.
- Proposal No. 2: Adjournment
- Status: Approved (but not utilized).
- Details: Granted authority to adjourn the meeting if necessary to solicit further votes. No motion to adjourn was made as it was deemed unnecessary.
- Votes: 4,199,681 For; 594,319 Against; 136,243 Abstain.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, or specific risk factors beyond the inherent uncertainty of the reverse stock split ratio, which has not yet been determined by the Board.
Investor Verification Checklist
- Monitor future public announcements for the specific reverse stock split ratio (1-for-2 to 1-for-50) and the effective date.
- Verify the impact of the approved reverse split on the number of outstanding shares and share price.
- Check subsequent filings for any changes in the company's capital structure or compliance with Nasdaq listing standards.